XOOMAR
Get a free API key

Elite Pharmaceuticals (ELTP)

Elite Pharmaceuticals on one page: short interest, fails to deliver, earnings dates and insider trades. Listed on OTC.

Download CSV

3.0M

Short interest

settlement 2026-10-15

1.8

Days to cover

-0.5 days vs prior

45,934

Fails to deliver

settlement 2026-07-02

Fri 13 Nov

Next earnings

estimated date

$35K

Insider flow, 90 days

2 buys, 0 sells

As of 2026-10-15.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in ELTP is 3,034,556 shares, up 427,926 shares over the last month. Over the last 48 readings it ranged from 1,560,478 shares (31 October 2024) to 3,034,556 shares (15 October 2026). The latest reading sits at the top of that range. At the reported average volume of 1.7M shares a day that is 1.8 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/eltp" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-10-153,034,556+15.3%1,738,2691.75
2026-09-302,632,127+1.0%1,177,4432.24
2026-09-152,606,630+2.3%1,685,9081.55
2026-08-312,547,855+1.5%1,880,8021.35
2026-08-142,510,800-6.5%2,006,8531.25
2026-07-312,685,456+3.3%720,4213.73
2026-07-152,599,593-2.1%1,374,7661.89
2026-06-302,654,887+2.3%1,292,9032.05
2026-06-152,594,622-0.2%1,697,9791.53
2026-05-292,599,516-0.9%801,1383.24
2026-05-152,622,325+6.0%1,004,4702.61
2026-04-302,473,767+1.6%1,161,8312.13
2026-04-152,435,723-0.6%673,2093.62
2026-03-312,449,194+6.5%1,210,8132.02
2026-03-132,298,661-6.2%1,503,8421.53
2026-02-272,449,531-3.5%2,254,9411.09
2026-02-132,538,952+21.0%1,518,4331.67
2026-01-302,098,448-2.7%1,431,6781.47
2026-01-152,155,786-2.0%929,8202.32
2025-12-312,198,798-0.4%1,315,2811.67
2025-12-152,207,729-1.0%1,094,8262.02
2025-11-282,229,689-5.7%2,201,8921.01
2025-11-142,365,428+11.1%1,345,4321.76
2025-10-312,128,899+1.1%1,261,5831.69
2025-10-152,106,780-7.0%1,519,7471.39
2025-09-302,265,901+2.5%2,066,5431.10
2025-09-152,210,633-12.3%2,761,9151.00
2025-08-292,521,859+7.0%5,163,1951.00
2025-08-152,355,954-4.8%2,817,2221.00
2025-07-312,475,220+1.0%1,587,2121.56
2025-07-152,449,782-4.9%4,610,6961.00
2025-06-302,576,656+11.2%5,731,1911.00
2025-06-132,317,236+1.0%4,068,2061.00
2025-05-302,293,327+17.0%1,687,0671.36
2025-05-151,960,515-1.4%1,440,4861.36
2025-04-301,987,621-0.0%885,3142.25
2025-04-151,988,454+1.0%2,850,5651.00
2025-03-311,968,404-0.8%1,207,0811.63
2025-03-141,984,033+0.1%1,163,5441.71
2025-02-281,982,012-5.8%2,031,6791.00
2025-02-142,104,956+3.6%2,630,1301.00
2025-01-312,031,571+3.0%1,560,0861.30
2025-01-151,972,524-1.8%3,051,5511.00
2024-12-312,008,349-26.1%2,648,4451.00
2024-12-132,717,734+7.6%3,098,3031.00
2024-11-292,526,504+52.7%4,808,3561.00
2024-11-151,654,545+6.0%4,053,1411.00
2024-10-311,560,478-22.1%14,522,5611.00

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 2 July 2026, the fails-to-deliver balance in ELTP is 45,934 shares, up 32,350 shares over the last settlement date. Over the last 30 readings it ranged from 49 shares (15 May 2025) to 146,059 shares (13 September 2024).

SettlementShares failedPriceValue
2026-07-0245,934$0.36$17K
2026-03-2513,584$0.38$5K
2025-12-193,218$0.49$2K
2025-10-14220$0.63$139
2025-09-0338,074$0.70$27K
2025-08-064,689$0.54$3K
2025-06-065,509$0.56$3K
2025-05-1549$0.44$22
2025-04-141,646$0.41$675
2025-04-114,925$0.42$2K
2025-04-081,834$0.35$642
2025-03-312,457$0.44$1K
2025-03-2710,000$0.47$5K
2025-03-26103$0.46$47
2025-03-061,053$0.48$505
2025-02-252,711$0.49$1K
2025-02-181,449$0.53$768
2025-02-103,739$0.52$2K
2025-01-131,231$0.50$616
2024-12-304,070$0.56$2K
2024-12-19915$0.55$503
2024-12-1115,433$0.57$9K
2024-11-0541,239$0.51$21K
2024-10-221,000$0.71$710
2024-09-301,662$0.39$648
2024-09-277,597$0.39$3K
2024-09-2537,200$0.38$14K
2024-09-1955,857$0.39$22K
2024-09-1697,278$0.36$35K
2024-09-13146,059$0.40$58K

Insider trades

SEC Form 4, newest first. JSON

Insiders at ELTP reported 2 open-market buys worth $35K in the last 90 days and no open-market sells. Latest filing: Dash Barry H (Director) on 2026-10-09.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-10-09Dash Barry HDirectorBuy100K$0.26$26K3.4M
2026-08-19Dash Barry HDirectorBuy30K$0.29$9K3.3M
2026-01-09Plassche DouglasEVP OperationsExercise or conversion2.5M$0.03$75K6.0M
2025-10-02Plassche DouglasEVP OperationsSell800K$0.62$499K3.5M
2025-08-25ELITE PHARMACEUTICALS INC /NV/EVP OperationsExercise or conversion2.5M$0.03$75K4.3M
2025-08-22ELITE PHARMACEUTICALS INC /NV/EVP OperationsSell500K$0.52$262K1.8M
2025-07-10Kirkov KirkoChief Commercial OfficerBuy16K$0.59$10K16K
2025-07-08Plassche DouglasEVP OperationsSell200K$0.58$116K2.3M
2025-07-03Plassche DouglasEVP OperationsExercise or conversion2.5M$0.03$75K2.5M
2024-10-24Plassche DouglasSVP of OperationsSell334K$0.51$170K0
2024-10-23Plassche DouglasSVP of OperationsSell800K$0.49$392K334K
2024-03-29Hakim Nasrat ACEO, PresidentGrant49.5M$0.00$0216.6M
2023-12-29Hakim Nasrat ACEO, PresidentGrant2.2M$0.07$156K2.2M
2023-11-22Dash Barry HDirectorGrant548K$0.04$22K3.2M
2023-11-22Caskey Davis SDirectorGrant548K$0.04$22K2.0M
2023-11-22WHITNELL JEFFREY ADirectorGrant548K$0.04$22K3.2M
2022-08-28Dash Barry HDirectorGrant460K$0.04$18K2.7M
2022-08-28Caskey Davis SDirectorGrant460K$0.04$18K1.5M
2022-08-28WHITNELL JEFFREY ADirectorGrant460K$0.04$18K2.6M
2021-06-30Dash Barry HDirectorGrant296K$0.07$21K2.2M
2021-06-30Caskey Davis SDirectorGrant296K$0.07$21K1.0M
2021-06-30WHITNELL JEFFREY ADirectorGrant296K$0.07$21K2.2M
2020-08-24Hakim Nasrat ACEO & PresidentConversion158.0M$0.00$0167.1M
2020-08-20Dash Barry HDirectorGrant517K$0.09$47K1.9M
2020-08-20WHITNELL JEFFREY ADirectorGrant517K$0.09$47K1.9M
2020-08-20Caskey Davis SDirectorGrant517K$0.09$47K747K
2020-08-20Plassche DouglasSVP OperationsGrant72K$0.09$6K1.1M
2020-06-30Plassche DouglasSVP of OperationsGrant575K$0.09$52K1.1M

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

What this page is

Elite Pharmaceuticals in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Elite Pharmaceuticals (ELTP), SEC CIK 1053369, listed on OTC. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-07-02.JSON and CSV
Earnings dates
SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-13.JSON and CSV
Insider trades
SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-09.JSON and CSV
Company record
EDGAR filing index for CIK 1053369Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Other company pages

Datasets

Frequently Asked Questions

How much of ELTP is sold short?
3,034,556 shares were held short at the 2026-10-15 settlement, 1.8 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is ELTP's daily short volume?
No daily short volume file lists ELTP yet.
Does ELTP have fails to deliver?
The SEC's latest file shows 45,934 ELTP shares failed to deliver at settlement 2026-07-02. Fails are reported per settlement date and published twice a month with a lag.
Are ELTP insiders buying or selling?
Insiders at ELTP reported 2 open-market buys worth $35K in the last 90 days and no open-market sells. Latest filing: Dash Barry H (Director) on 2026-10-09.

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.